NCT01688505

Brief Summary

Hypertension in midlife is an independent risk factor of late life cognitive dysfunction or dementia. Chronic hypertension cause vascular damage and cerebral ischemia, which ultimately gives rise to the cognitive dysfunction or dementia. A recent study showed that high visit-to-visit variability in clinic systolic blood pressure (BP) was a strong independent predictor of stroke. This finding suggests that high clinic systolic BP variability itself as well as chronic hypertension may cause vascular damage and cerebral ischemia. Therefore, high clinic SBP variability may be also an independent risk factor of cognitive dysfunction or dementia. Vascular damage leads to the diminished autoregulatory capacities of cerebral arteries. The brain with the reduced autoregulatory capacity may be more vulnerable to BP fluctuation. Therefore, high BP variability may be more harmful in patients with damaged vessels (for example, in patients with cerebral small vessel disease). Previous data about BP variability and cognition revealed very controversial. Some studies showed poor cognition in patients with high BP variability, but others did not. The previous studies were mostly based on cross-sectional designs, and performed in small-sized heterogeneous population for primary prevention. The harmful effect of high BP variability may be clearer in the population with damaged vascular bed, such as cerebral small vessel disease. The previous studies usually used ambulatory BP monitoring (ABPM). However, recent data suggested that variability in BP on ABPM may be a weaker predictor of vascular events than be visit-to-visit variability in clinic BP. The investigators sought to find whether high visit-to-visit variability in clinic BP is related with poor cognitive function in patients with cerebral small vessel disease.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2012

Shorter than P25 for all trials

Geographic Reach
1 country

5 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2012

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

September 16, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 20, 2012

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2013

Completed
Last Updated

September 20, 2012

Status Verified

September 1, 2012

Enrollment Period

9 months

First QC Date

September 16, 2012

Last Update Submit

September 19, 2012

Conditions

Keywords

cerebral small vessel diseasescognitive impairmentBlood pressure variability

Outcome Measures

Primary Outcomes (1)

  • Association between raw score of K-MMSE and visit-to-visit systolic BP variability

    Difference of mean K-MMSE raw scores between the highest and the lowest tertile group stratified by visit-to-visit systolic BP variability: Wilcoxon\_Mann\_Whitney test Binary logistic regression analysis for independent association between visit-to-visit systolic BP variability and low cognition, including confounding variables with p\<0.2 in univariate analysis (Low cognition, defined as the lowest tertile of K-MMSE raw score)

    Time from previous MRI documentation as small vessel disease to cognitive function evaluation; 1.5 to 7 years

Secondary Outcomes (3)

  • Association between raw score of K-MMSE and visit-to-visit diastolic BP variability

    Time from previous MRI documentation as small vessel disease to cognitive function evaluation; 1.5 to 7 years

  • Association between raw scores of "K-VCI NP 30-minute protocol" sub-tests and visit-to-visit systolic BP variability

    Time from previous MRI documentation as small vessel disease to cognitive function evaluation; 1.5 to 7 years

  • Association between raw scores of "K-VCI NP 30-minute protocol" sub-tests and visit-to-visit diastolic BP variability

    Time from previous MRI documentation as small vessel disease to cognitive function evaluation; 1.5 to 7 years

Study Arms (1)

Visit-to-visit BP variability

The highest, intermediate, and the lowest visit-to-visit BP variability (Tertile grouping)

Eligibility Criteria

Age60 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Outpatients of stroke clinic in secondary or tertiary hospitals

You may qualify if:

  • Patients with cerebral small vessel disease previously documented on MRI (definition of small vessel disease - symptomatic lacunar infarction or white matter ischemic lesion with one or more asymptomatic lacunes)

You may not qualify if:

  • Incomplete clinic BP data (less than 6 BP readings during recent one year)
  • History of cardiovascular or cerebrovascular events during recent one year
  • Documented cerebral infarction from large artery atherosclerosis
  • Atrial fibrillation or cardiac disease with high risk of embolism
  • Significant medical, neurological, or psychiatric disease affecting cognition
  • Known dementia treated with acetylcholine esterase inhibitor or memantine
  • Patients without informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Chuncheon Sacred Heart Hospital, Hallym University, College of Medicine

Chuncheon, Gangwon-do, 200-704, South Korea

RECRUITING

Hallym University Sacred Heart Hospital, Hallym University, College of Medicine

Anyang-si, Gyeonggi-do, 431-796, South Korea

RECRUITING

Gangdong Sacred Heart Hospital, Hallym University, College of Medicine

Seoul, 134-701, South Korea

RECRUITING

Hangang Sacred Heart Hospital, Hallym University, College of Medicine

Seoul, 150-719, South Korea

RECRUITING

Gangnam Sacred Heart Hospital, Hallym University, College of Medicine

Seoul, 150-950, South Korea

RECRUITING

MeSH Terms

Conditions

Cerebral Small Vessel DiseasesCognitive Dysfunction

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesCognition DisordersNeurocognitive DisordersMental Disorders

Central Study Contacts

Kyung-Ho Yu, MD. PhD.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 16, 2012

First Posted

September 20, 2012

Study Start

May 1, 2012

Primary Completion

February 1, 2013

Study Completion

February 1, 2013

Last Updated

September 20, 2012

Record last verified: 2012-09

Locations